Table 1 .
Individual multidisciplinary team survey responses between 15 April and 30 June 2020
| Cohort characteristics | n (%) |
|---|---|
| CCR during COVID-19 pandemic (N = 67) | |
| Yes | 57 (85.1) |
| No | 10 (14.9) |
| Preoperative COVID-19 screening (N = 59) | |
| Yes | 50 (84.7) |
| No | 9 (15.3) |
| Full PPE for elective cases (N = 59) | |
| Yes | 50 (84.7) |
| No | 8 (13.6) |
| Only suspected/confirmed cases | 1 (1.7) |
| Planned laparoscopic cases (N = 58) | |
| Performed as laparoscopic | 25 (42.1) |
| Performed as open instead | 28 (48.3) |
| Performed using other approach | 5 (8.6) |
| Complications from CCR (N = 59) | |
| Yes | 7 (11.9) |
| No | 52 (88.1) |
| If cancer resections cancelled, were additional neoadjuvant treatments used | |
| Yes | 24 (38.7) |
| Short-course radiotherapy | 16 (23.9) |
| Chemoradiotherapy | 1 (1.5) |
| Chemotherapy | 1 (1.5) |
| Biological therapy | 1 (1.5) |
| No response | 5 |
| No | 38 (61.3) |
| Cancers re-staged after neoadjuvant therapy (N = 60) | 60 (100) |
CCR = colorectal cancer resections; PPE = personal protective equipment.